Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders.
Nat Med. 2023 Dec;29(12):2993-2995. doi: 10.1038/s41591-023-02634-8.
Nat Med. 2023.
PMID: 38001271
No abstract available.
Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial.
Antonsen KK, Klausen MK, Brunchmann AS, le Dous N, Jensen ME, Miskowiak KW, Fisher PM, Thomsen GK, Rindom H, Fahmy TP, Vollstaedt-Klein S, Benveniste H, Volkow ND, Becker U, Ekstrøm C, Knudsen GM, Vilsbøll T, Fink-Jensen A.
Antonsen KK, et al. Among authors: klausen mk.
BMJ Open. 2018 Jul 16;8(7):e019562. doi: 10.1136/bmjopen-2017-019562.
BMJ Open. 2018.
PMID: 30012779
Free PMC article.
Item in Clipboard
Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent.
Jensen ME, Galli A, Thomsen M, Jensen KL, Thomsen GK, Klausen MK, Vilsbøll T, Christensen MB, Holst JJ, Owens A, Robertson S, Daws L, Zanella D, Gether U, Knudsen GM, Fink-Jensen A.
Jensen ME, et al. Among authors: klausen mk.
Neurochem Int. 2020 Sep;138:104772. doi: 10.1016/j.neuint.2020.104772. Epub 2020 May 25.
Neurochem Int. 2020.
PMID: 32464226
Free PMC article.
Item in Clipboard
The role of glucagon-like peptide 1 (GLP-1) in addictive disorders.
Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A.
Klausen MK, et al.
Br J Pharmacol. 2022 Feb;179(4):625-641. doi: 10.1111/bph.15677.
Br J Pharmacol. 2022.
PMID: 34532853
Free PMC article.
Review.
Item in Clipboard
Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial.
Klausen MK, Jensen ME, Møller M, Le Dous N, Jensen AØ, Zeeman VA, Johannsen CF, Lee A, Thomsen GK, Macoveanu J, Fisher PM, Gillum MP, Jørgensen NR, Bergmann ML, Enghusen Poulsen H, Becker U, Holst JJ, Benveniste H, Volkow ND, Vollstädt-Klein S, Miskowiak KW, Ekstrøm CT, Knudsen GM, Vilsbøll T, Fink-Jensen A.
Klausen MK, et al.
JCI Insight. 2022 Oct 10;7(19):e159863. doi: 10.1172/jci.insight.159863.
JCI Insight. 2022.
PMID: 36066977
Free PMC article.
Clinical Trial.
Item in Clipboard
The LIVER CARE trial - screening for liver disease in individuals attending treatment for alcohol use disorder: a randomized controlled feasibility trial.
Jepsen P, von Wowern N, Madsen LG, Klausen MK, Düring S, Benthien KS, Winther-Jensen M, Petersen J, Askgaard G.
Jepsen P, et al. Among authors: klausen mk.
Pilot Feasibility Stud. 2024 May 16;10(1):78. doi: 10.1186/s40814-024-01504-5.
Pilot Feasibility Stud. 2024.
PMID: 38755732
Free PMC article.
Item in Clipboard
Cite
Cite